Podcast appearances and mentions of sally susman

You're a leader at a global pharmaceutical company and a once-in-a-lifetime worldwide pandemic hits. How do you manage that with bold leadership and resilience - all while maintaining a sense of humor? Sally Susman, Chief Corporate Affairs Officer at Pfizer, shares how she navigated the unprecedented, along with some hilarious stories from her career:The power of admitting you're wrong and sharing your biggest mistakesHer future boss' witty answer when someone offered to trade her for a couple of cows An embarrassing interview about her footwear with one of the nation's largest newspapersWe also encourage you to pick up a copy of Sally's fantastic best-selling book, Breaking through: Communicating to Open Minds, Move Hearts and Change the World,” published by Harvard Business Review Press.

In this episode, we mark a big milestone with a gift-wrapped edition of the Internal Comms Podcast. It's six years since the show launched and, in this Christmas special, host Katie Macaulay shares some of her favourite moments. From Professor William Kahn's take on the meaning of engagement, to Seth Godin on creating the right conditions for people to change their attitude, via the Chief Corporate Affairs Officer at Pfizer, Sally Susman, on transforming “the reputation of the company alongside the development of the COVID vaccine”, you'll discover some great insight into the ever-changing world of IC from some of the professions' top names. This episode marks a wrap for season 12. Share your favourite moments using #TheICPodcast on LinkedIn and tune back in early 2025 as we kick off season 13.

The Power of Communication: Insights from Sally Susman, Author of 'Breaking Through'   In this episode, Aiden welcomes Sally Susman, author of 'Breaking Through: Communicating to Open Minds, Move Hearts, and Change the World' to discuss the vital role of communication in professional and personal settings. Sally shares insights from her extensive career, including her experiences working with top leaders at Pfizer, Estee Lauder, and American Express. The discussion explores the misconception of communication as a soft skill, the importance of authentic outreach, the power of gratitude, and Susman's innovative approaches during the COVID-19 pandemic. Sally also emphasises curiosity, creativity, and intentionality as key components for effective communication. Throughout the episode, real-life anecdotes and practical advice offer listeners valuable lessons on leadership and connection.   00:00 Introduction and Guest Welcome 00:39 The Importance of Communication 03:24 Lessons from Estee Lauder 06:09 Personal Background and Family Influence 08:51 The Power of Gratitude 13:15 Perfecting Your Pitch 23:02 Humour in the Workplace 29:36 Challenges at Pfizer 32:03 Facing the Biopharma Reputation Challenge 33:37 The Pandemic's Impact and New Leadership 35:02 Albert Bourla's Bold Vision 36:30 Revolutionising Vaccine Development 37:25 The Media's Role in the Journey 38:55 Pfizer's Transformation and Recognition 40:46 Innovative Leadership and Personal Growth 49:30 Curiosity and Creativity in Action 56:47 The Power of Intentionality 58:46 Concluding Thoughts and Inspirations

Communications is the CENTER OF ALL THINGS. On the pod, Lee interviews interesting communications pros, CEOs, branding experts, and authors to bring key insights that can be used in the day to day to make your work, your PR, your marketing WORK. Occasionally, she goes it alone to share her thoughts and insights on key topics of the day in solo shows. Today is a Solo Show with your host, Lee Caraher. What you will learn in this episode: Lee's six summer reading recommendations to become a better communicator by fall How to become a better leader through Leadership and the Art of Conversation How to create a repeatable message that carries impact through Talk Triggers How to present with confidence and be compelling through Better Presentations How to emulate super communicators to become one yourself through Supercommunicators How to connect with your audience through representation and new points of view through Speaking While Female Resources: Book Recommendations: Leadership & The Art of Conversation by Kim Krisco: https://a.co/d/37iHpQJ Talk Triggers by Jay Baer & Daniel Lemin: https://a.co/d/2mQzGzO Breaking Through: Communicating to Open Minds, Move Hearts, and Change the World by Sally Susman: https://a.co/d/aVWEJFn The Non-Obvious Guide to Better Presentations: How to Present Like a Pro (Virtually or in Person) by Jacqueline Farrington: https://a.co/d/ds5tAOK Supercommunicators: How to Unlock the Secret Language of Connection by Charles Duhigg: https://a.co/d/dv3JzuC Speaking While Female: 75 Extraordinary Speeches by American Women by Dana Rubin: https://a.co/d/3pjmWhL Website: https://leecaraher.com/ Website: www.double-forte.com Instagram: https://www.instagram.com/leecaraher/ LinkedIn: https://www.linkedin.com/in/leecaraher Facebook: https://www.facebook.com/LeeCaraher1/ Twitter: https://twitter.com/leecaraher  

Sally Susman is a world-class communicator, an author of "Breaking Through: Communicating to Open Minds, Move Hearts, and Change the World", and – of course – a former staffer. Tune in to this episode to hear lessons she learned and stories she lived during her journey from a Senate mail room to the U.S. Department of Commerce to some of the country's biggest brands -- American Express, Estée Lauder, and Pfizer. Follow STAFFER on Twitter, Facebook, Instagram, & LinkedIn

We're looking back at some of our favorite moments from Season Two of The TrustMakers. Take a listen to hear trust-building insights from Kofi Amoo-Gottfried, CMO of DoorDash; Manu Meel, CEO of BridgeUSA; Tim Davie, Director General of the BBC; Sally Susman, EVP and Chief Corporate Affairs Officer of Pfizer; C.D. Glin, President of the … Continue reading "Top Trust Tips From Season Two"

Sally Susman, Executive Vice President and Chief Corporate Affairs Officer at Pfizer and author of Breaking Through joins our host Kevin Kajiwara on the Teneo Insights Series. Sally shares insights from her long-standing career as a trailblazing communications leader and the important lessons she learned along the way; how she led corporate affairs at Pfizer during the COVID-19 pandemic and through the vaccine rollout; and the importance of breaking through the noise and communicating with intention and authenticity in our turbulent world.

Sally Susman is Executive Vice President and Chief Corporate Affairs Officer at Pfizer. She is also Vice Chair of the Pfizer Foundation. Sally leads engagement with all of Pfizer's external stakeholders, overseeing communications, corporate responsibility, global policy, government relations, investor relations, and patient advocacy. Before joining Pfizer in 2007, she held several senior communications and government relations roles at Estée Lauder Companies and the American Express Company. https://www.sallysusman.com

Dear listeners, this week we celebrate our 100th episode. We want to take this opportunity to thank you for your support and listenership, as we treat you to a compilation of some of our favorite insights over the past years. Below you'll find a highlights reel broken down into clips in four categories:CLASSIC STRATEGY: Featuring Rita, McGrath, Richard Rumelt, John Hagel, and Mike Tushman who each share with us timeless ideas around strategy.LEADERSHIP, CULTURE & WORKFORCE: Featuring Adam Bryant, Ajay Banga, Sally Susman, Johnny C. Taylor, Tiffani Bova, and Elizabeth Altman, who each share critical insights into leadership, our employees, and the quickly changing landscape of the workforce.VALUE CREATION: Featuring Felix Oberholzer-Gee, Thales Teixeira, Pete Fader, and Mohan Subramaniam, who each share alternative and modern views around value creation.INNOVATION, TECH & THE FUTURE: Featuring Alex Osterwalder, Rob Wolcott, Vivek Wadhwa, and Faith Popcorn who each share with us insightful ideas around innovation, upcoming trends in tech and society, and the future of business._________________________________________________________________________________________Episode Timeline:00:34—Special Introduction to 100th Episode from KaihanCLASSIC STRATEGY2:57—Highlight from Rita McGrath: Strategic Planning Amidst Uncertainty5:24—Highlight from Richard Rumelt: Finding the Crux of Your Strategy7:01—Highlight from John Hagel: Why You Should "Zoom Out, Zoom In," and Scale From the Edge9:01—Highlight from Mike Tushman: Why Ambidextrous Organizations Outperform OthersLEADERSHIP/CULTURE/WORKFORCE10:52—Highlight from Adam Bryant: Good vs. GREAT CEOs—500 Interviews Reveal What Makes the Difference12:58—Highlight from Ajay Banga: Insights from a Former CEO with Ajay Banga of MasterCard15:11—Highlight from Sally Susman: Insights from Pfizer's Chief Corporate Affairs Officer in Crafting Public Discourse17:27—Highlight from Johnny C. Taylor: Trends You Need to Know About the Workforce19:27—Highlight from Tiffani Bova: Elevating Your EX to Improve Your CX21:01—Highlight from Elizabeth Altman: Rethinking the Definition of a Workforce in the Modern EraVALUE CREATION23:24—Highlight from Felix Oberholzer-Gee: Applying a Value-Based Strategy to Drive Your Business26:11—Highlight from Thales Teixeira: Decoupling the Customer Value Chain for Competitive Advantage28:36—Highlight from Pete Fader: Becoming a Customer-Centric Business30:49—Highlight from Mohan Subramaniam: The Future of Competitive Strategy and the Evolving Role of Data, Customers and Digital EcosystemsINNOVATION, TECH & THE FUTURE33:46—Highlight from Alexander Osterwalder: How Investing in Culture Ecosystems Leads to Innovation35:57—Highlight from Rob Wolcott: The Power of Proximity in your Strategy38:31—Highlight from Vivek Wadhwa: Harnessing Tech for an Innovative Future40:24—Highlight from Faith Popcorn: Predictions to Know From a Leading Futurist42:34—Closing and Thank you

Dear listeners, this week we celebrate our 100th episode. We want to take this opportunity to thank you for your support and listenership, as we treat you to a compilation of some of our favorite insights over the past years. Below you'll find a highlights reel broken down into clips in four categories:CLASSIC STRATEGY: Featuring Rita, McGrath, Richard Rumelt, John Hagel, and Mike Tushman who each share with us timeless ideas around strategy.LEADERSHIP, CULTURE & WORKFORCE: Featuring Adam Bryant, Ajay Banga, Sally Susman, Johnny C. Taylor, Tiffani Bova, and Elizabeth Altman, who each share critical insights into leadership, our employees, and the quickly changing landscape of the workforce.VALUE CREATION: Featuring Felix Oberholzer-Gee, Thales Teixeira, Pete Fader, and Mohan Subramaniam, who each share alternative and modern views around value creation.INNOVATION, TECH & THE FUTURE: Featuring Alex Osterwalder, Rob Wolcott, Vivek Wadhwa, and Faith Popcorn who each share with us insightful ideas around innovation, upcoming trends in tech and society, and the future of business._________________________________________________________________________________________Episode Timeline:00:34—Special Introduction to 100th Episode from KaihanCLASSIC STRATEGY2:57—Highlight from Rita McGrath: Strategic Planning Amidst Uncertainty5:24—Highlight from Richard Rumelt: Finding the Crux of Your Strategy7:01—Highlight from John Hagel: Why You Should "Zoom Out, Zoom In," and Scale From the Edge9:01—Highlight from Mike Tushman: Why Ambidextrous Organizations Outperform OthersLEADERSHIP/CULTURE/WORKFORCE10:52—Highlight from Adam Bryant: Good vs. GREAT CEOs—500 Interviews Reveal What Makes the Difference12:58—Highlight from Ajay Banga: Insights from a Former CEO with Ajay Banga of MasterCard15:11—Highlight from Sally Susman: Insights from Pfizer's Chief Corporate Affairs Officer in Crafting Public Discourse17:27—Highlight from Johnny C. Taylor: Trends You Need to Know About the Workforce19:27—Highlight from Tiffani Bova: Elevating Your EX to Improve Your CX21:01—Highlight from Elizabeth Altman: Rethinking the Definition of a Workforce in the Modern EraVALUE CREATION23:24—Highlight from Felix Oberholzer-Gee: Applying a Value-Based Strategy to Drive Your Business26:11—Highlight from Thales Teixeira: Decoupling the Customer Value Chain for Competitive Advantage28:36—Highlight from Pete Fader: Becoming a Customer-Centric Business30:49—Highlight from Mohan Subramaniam: The Future of Competitive Strategy and the Evolving Role of Data, Customers and Digital EcosystemsINNOVATION, TECH & THE FUTURE33:46—Highlight from Alexander Osterwalder: How Investing in Culture Ecosystems Leads to Innovation35:57—Highlight from Rob Wolcott: The Power of Proximity in your Strategy38:31—Highlight from Vivek Wadhwa: Harnessing Tech for an Innovative Future40:24—Highlight from Faith Popcorn: Predictions to Know From a Leading Futurist42:34—Closing and Thank you

We're ending Season 9 of the Internal Comms Podcast with a bang this week, as Sally Susman takes to the hot seat for her second appearance. Sally is Executive Vice President and Chief Corporate Affairs Office at Pfizer, and on episode 55 she shared with Katie what it was like being on the company's vaccine development task force and being in the room when the US Federal Drug Authority gave the vaccine the green light. This time, she's back to take a deep dive into her book Breaking Through: Communicating to Open Minds, Move Hearts and Change the World. Sally shares candid stories from the book, including a toe-curling account of a costly mistake when working for a US Senator. As Sally reflects, “it's in these moments when we suffer embarrassment that we really stretch ourselves, learn and grow”. Beyond these anecdotes, Katie and Sally discuss when corporations should speak up, the blurred lines between external and internal communications, and even Pfizer's unexpected fourth corporate value. This episode is jam-packed with equal parts wisdom and humour. It's not one to be missed. As always, share your thoughts of this or any other episode of the Internal Comms Podcast using the hashtag #TheICPodcast. And thanks for listening.

In March of 2020, Sally Susman, the chief corporate affairs officer at Pfizer, found herself at the helm of one of the most urgent high stakes public dialogues of our times. She and her team successfully found ways to break through and persuade millions to change their assumptions about big pharma and build confidence in the life-saving technology they developed. ***The Burleson Box is brought to you by Mastry:The Mastry App leverages HypnoBreathwork®, a cutting edge method using breathwork to clear energetic patterns, hypnosis to reprogram subconscious beliefs, and visioning to fire new neural pathways for sustainable behavior change. This unique formula accelerates trance-induced states to heal unprocessed emotions from the root and take intuitive action to get into alignment.Mastry is an experience to create connection and live your purpose. Download the app, try a free 7 day tray and join the mailing list at Mastryapp.com***Resources Mentioned in the Episode with Sally Susman:Sally SusmanAlbert BourlaLeonard Lauder***Go Premium: Members get early access, ad-free episodes, hand-edited transcripts, exclusive study guides, special edition books each quarter, powerpoint and keynote presentations and two tickets to Dustin Burleson's Annual Leadership Retreat.http://www.theburlesonbox.com/sign-up Stay Up to Date: Sign up for The Burleson Report, our weekly newsletter that is delivered each Sunday with timeless insight for life and private practice. Sign up here:http://www.theburlesonreport.com Follow Dustin Burleson, DDS, MBA at:http://www.burlesonseminars.com

Wednesday's PRWeek Healthcare Conference + Awards in New York marked a new milestone for the brand: its first-ever live podcast — and it has guests worthy of the occasion. PRWeek editorial director Steve Barrett was joined on stage by Sally Susman, EVP and chief corporate affairs officer at Pfizer, who discussed her experiences working on communications during the COVID-19 vaccine, batting away disinformation and why comms is more of a hard skill than a soft skill.Joining Susman was Edelman CEO Richard Edelman, who discussed building healthcare expertise at an agency, winning over skeptics on issues such as vaccines and working with controversial clients.Plus a conversation between the two industry heavyweights on building consensus and taking on controversial political and social issues. Follow us on Twitter: @PRWeekUSReceive the latest industry news, insights, and special reports. Start Your Free 1-Month Trial Subscription To PRWeek

Communication is a critical skill for leaders and company culture. In this episode, Real Chemistry Founder and Chairman Jim Weiss is joined by Sally Susman, Chief Corporate Affairs Officer of Pfizer and author of "Breaking Through," who shares her insights on the importance of communication in leadership, building corporate and product brands, and navigating challenging conversations. 

Sally Susman is Executive Vice President and Chief Corporate Affairs Officer at Pfizer. She is also Vice Chair of the Pfizer Foundation. Sally leads engagement with all of Pfizer's external stakeholders, overseeing communications, corporate responsibility, global policy, government relations, investor relations, and patient advocacy. Before joining Pfizer in 2007, she held several senior communications and government relations roles at Estée Lauder Companies and the American Express Company.Through these extensive career experiences, Sally has honed an acute sense of how to navigate the delicate conversation that an organization must perpetually engage in with their stakeholders. And her work and expertise are more needed now than ever. With the growing interest among consumers, investors, and the community in the companies they support doing the right thing, your corporations' success depends, more so than perhaps any time in history, on your ability to strategically approach the complex challenges of when to take stand, what stand to take, and how to authentically community your corporate stance to the world. In this episode, she shares: The 5 questions leaders can ask to determine what discourses they will engage in with the public, especially in this modern era where that channel is never “off' How an organization can work in a collaborative way with their leadership and corporate affairs team to craft a united message that reflects company values The principles to mastering “informal influence”—getting others to be willing to adopt your ideas, as discussed in her most recent book, BREAKING THROUGH: Communicating to Open Minds, Move Hearts, and Change the World Why communications is not a nice-to-have soft skill, but an essential capability that any leader or company must master_________________________________________________________________________________________Episode Timeline:00:00—Highlight from today's episode00:52—Introducing Sally + The topic of today's episode3:00—If you really know me, you know that...4:14—What is your definition of strategy?4:37—Can you tell us about a document Pfizer has developed called a "purpose blueprint"?6:00—What made you make the career shift from a government to corporate role?7:27—It seems that there is now a more pronounced expectation for corporations to channel their impact in the world, why do you think this is taking place, and why now?9:47—What are some suggestions you can share from the experience of navigating really high-stakes, fast moving moments?12:20—Could you tell us about how Pfizer navigated the Russian/Ukraine crisis?13:45—How does a leadership team approach creating a communication plan so that it's coming from authority? 15:07—Could you talk about the personal story in chapter two of your book regarding approaching difficult moments with courage and candor?17:48—Is there something you've changed your mind about?18:45—Any advice for being effective at using communication for informal influence?22:21—How can people follow you and keep learning from you?__________________________________________________________________________________________Additional Resources: Personal Page: https://www.sallysusman.com/Pfizer Profile Page: https://www.pfizer.com/people/leadership/executives/sally_susmanLinkedin: https://www.linkedin.com/in/sallysusmanBreaking Through book: https://www.sallysusman.com/the-book

Sally Susman is Executive Vice President and Chief Corporate Affairs Officer at Pfizer. She is also Vice Chair of the Pfizer Foundation. Sally leads engagement with all of Pfizer's external stakeholders, overseeing communications, corporate responsibility, global policy, government relations, investor relations, and patient advocacy. Before joining Pfizer in 2007, she held several senior communications and government relations roles at Estée Lauder Companies and the American Express Company.Through these extensive career experiences, Sally has honed an acute sense of how to navigate the delicate conversation that an organization must perpetually engage in with their stakeholders. And her work and expertise are more needed now than ever. With the growing interest among consumers, investors, and the community in the companies they support doing the right thing, your corporations' success depends, more so than perhaps any time in history, on your ability to strategically approach the complex challenges of when to take stand, what stand to take, and how to authentically community your corporate stance to the world. In this episode, she shares: The 5 questions leaders can ask to determine what discourses they will engage in with the public, especially in this modern era where that channel is never “off' How an organization can work in a collaborative way with their leadership and corporate affairs team to craft a united message that reflects company values The principles to mastering “informal influence”—getting others to be willing to adopt your ideas, as discussed in her most recent book, BREAKING THROUGH: Communicating to Open Minds, Move Hearts, and Change the World Why communications is not a nice-to-have soft skill, but an essential capability that any leader or company must master_________________________________________________________________________________________Episode Timeline:00:00—Highlight from today's episode00:52—Introducing Sally + The topic of today's episode3:00—If you really know me, you know that...4:14—What is your definition of strategy?4:37—Can you tell us about a document Pfizer has developed called a "purpose blueprint"?6:00—What made you make the career shift from a government to corporate role?7:27—It seems that there is now a more pronounced expectation for corporations to channel their impact in the world, why do you think this is taking place, and why now?9:47—What are some suggestions you can share from the experience of navigating really high-stakes, fast moving moments?12:20—Could you tell us about how Pfizer navigated the Russian/Ukraine crisis?13:45—How does a leadership team approach creating a communication plan so that it's coming from authority? 15:07—Could you talk about the personal story in chapter two of your book regarding approaching difficult moments with courage and candor?17:48—Is there something you've changed your mind about?18:45—Any advice for being effective at using communication for informal influence?22:21—How can people follow you and keep learning from you?__________________________________________________________________________________________Additional Resources: Personal Page: https://www.sallysusman.com/Pfizer Profile Page: https://www.pfizer.com/people/leadership/executives/sally_susmanLinkedin: https://www.linkedin.com/in/sallysusmanBreaking Through book: https://www.sallysusman.com/the-book

After the red light goes off on our This is Working live show, we cajole guests to stick around for quick answers to questions about productivity and career growth — a feature called This is Quick. In this week's session, Sally Susman talks about why she always carries walking shoes on a business trip, how having a fantastic mentor supercharged her career, and what she and her team have gained by sharing their mistakes. Got questions you want to hear Editor in Chief Dan Roth ask? Share a post or comment with the hashtag #ThisIsWorking on LinkedIn, or drop us a line - you can reach us at ThisIsWorking@Linkedin.com. Follow Sally Susman and Dan Roth on LinkedIn. You can watch Dan's full interview with Sally here.  Get this conversation and more delivered directly to your inbox by subscribing to the newsletter. It's also called This is Working!

On our latest episode of This is Working, our hosts revisit Dan's recent conversation with Sally Susman, Pfizer's Chief Corporate Affairs Officer, and author of the new book Breaking Through. Dan and Nina share excerpts of the interview with Sally, work out the finer points of communicating during a crisis, and dive deep on Sally's decision to embed a documentary crew with the teams of scientists who worked on Pfizer's Covid-19 vaccine. Nina and Dan will offer their own opinions - and we're eager to hear yours as well. Jump into the conversation on LinkedIn by sharing a post or comment with the hashtag #ThisIsWorking, or drop us a line - you can reach us at ThisIsWorking@Linkedin.com. Follow Sally Susman, Nina Melendez, and Dan Roth on LinkedIn. You can watch Dan's full interview with Sally here.  Get this conversation and more delivered directly to your inbox by subscribing to the newsletter. It's also called This is Working!

SEGMENT‌ ‌1 with Sally Susman,‌ ‌‌starting‌ ‌at‌ ‌0:00‌:‌ ‌ Chief Corporate Affairs Officer at Pfizer, ‌ Sally Susman, shares her experience of being part of the movement that introduced lifesaving Covid-19 vaccines to the world. “The world was depending on us. But vaccine skepticism, suspicion around Big Pharma's motives, economic insecurity, political polarization, civil unrest, and just plain fear were challenges we had to recognize and respect. We had to address those challenges in a way that didn't alienate people but, instead, brought them into the conversation. Was I up to the task? I'd have to be.” SEGMENT‌ ‌2 with Alexandra Allred,‌ ‌‌starting‌ ‌at‌ 16:45:‌ ‌ Alexandra Allred goes beyond the record books and gold medal counts to truly dig into the vital role women and sports have played in instigating change in society as a whole. SEGMENT‌ ‌3 with Emily Washcovick,‌ ‌‌starting‌ ‌at 36:30‌:‌ ‌ Do not fear a bad review! Just be prepared to respond to it. Emily Washcovick shares why you need to engage with good and bad online reviews, and how to utilize review sites like Yelp in your marketing strategy. Sponsored by Truly Financial.Visit Barry's Blog for complete show notes.

Sally Susman, Chief Corporate Affairs Officer at Pfizer, found herself at the helm of one of the most urgent, high-stakes public dialogues of our times. Based on her flash of insight, she and her team found ways to break through the noise and fear and persuade millions to change their assumptions about Big Pharma, make complex science accessible, and build confidence in the lifesaving technology.  Susman joins the Steve Cochran Show to share hard-earned lessons not only from the pandemic but from her life and distinguished career, from growing up in St. Louis, to the steps of Capitol Hill, to the corridors of corporate America, including senior positions at American Express and Estée Lauder. The vivid stories, from her own and other high-profile successes and missteps, provide a masterclass for communicating with authority and authenticity.See omnystudio.com/listener for privacy information.

Join EVP and Chief Corporate Affairs Officer at Pfizer, Sally Susman, as she discusses the importance of intentional communication, both personally and professionally. Sally shares how her experiences have helped her find her voice and how others can do the same.

Edelman's Kirsty Graham is joined by Sally Susman, Pfizer's Chief Corporate Affairs Officer. Sally discusses how the business of communications changed throughout the pandemic, how women can support each other in the workplace and the essential elements of leadership within a company. “It's important that we build cultures, that we work together, that we create … Continue reading "Pfizer's Sally Susman on Breakthrough Communications"

Impossible co-hosts Ashley Miles & Megan Rokosh are here to wrap up the season 1 recap & highlights review. Follow along as they revisit interviews with powerhouse guests like Tamsen Fadal, Tracey Ryans, Sally Susman, and Raegan L. Burden, MMC.  Listen as Ashley & Megan dissect the key findings of each episode and share how they applied these lessons to their own career and personal life. We hope you enjoy this enriching, full-circle episode dedicated to the amazing Impossible community! It's been a wonderful first season. Thank you for your continued support! CONNECT WITH IMPOSSIBLE ON INSTAGRAM AND YOUTUBE for the latest Impossible news, episode teasers, conversations with the Impossible community, and more.https://www.theimpossiblepodcast.com/www.instagram.com/the.impossible.podcast/https://www.youtube.com/c/ImpossiblePodcastOfficial 

On this momentous edition of Impossible, we're joined by a timely, legendary leader. Meet Sally Susman; a former midwestern gal, mother, proud wife, and Pfizer's Executive Vice President and Chief Corporate Affairs Officer. In the past few years, Sally's career exceeded her wildest expectations when she went on to helm the project of a lifetime with her world-class team: developing the world's leading COVID vaccine amid a life-altering pandemic. Listen as Sally pulls back the curtain on what it was like to overcome the impossible in racing against the clock to mass-produce a life-saving vaccine to fight COVID-19. In the past year, Forbes named Sally one of the World's Most Influential CMOs for leading Pfizer's brand evolution and communicating the story around the company's internationally-dispersed vaccine.Aside from Sally's stacked professional resume, she has created space for LGBTQ+ professionals to show up as their full, authentic selves in the workplace — without shame or stigma. Above all, Sally strives to lead with kindness daily. In her words, “The kinder you are, the more you will soar.”This episode is jam-packed with moving stories including: crushing setbacks, moments of growth, and immense triumph. Buckle up for our biggest Impossible episode to date. Our world is a better place because of Sally and we're so honored to have her on Impossible! CONNECT WITH IMPOSSIBLE ON INSTAGRAM AND YOUTUBE for the latest Impossible news, episode teasers, conversations with the Impossible community, and more.https://www.theimpossiblepodcast.com/www.instagram.com/the.impossible.podcast/

This episode features a candid conversation between Sally Susman, executive vice president and chief corporate affairs officer at Pfizer and Dustee Jenkins, president of New York Women in Communications and the global head of communications for Spotify. As part of our new WomenHeard podcast, we're thrilled to be sharing conversations with incredible women and this one features insightful advice about networking, navigating career changes, and effective leadership. It also includes an exclusive look into what it was like inside Pfizer at the beginning and throughout the Covid-19 pandemic so far. This interview was recorded as part of the exciting new "In the Room" series, brought to you by New York Women in Communications. For more information about future events like this one, please visit nywici.org.

“There have been times when my team has proposed something, and I say, ‘Let's do it,' and then we get blow-back very swiftly. Do you know what we do? We take it down, and we move on. You can't succeed in this realm if you're not willing to fail in this realm.” Sally Susman is the EVP & Chief Corporate Affairs Officer at Pfizer, U.S., where she leads engagement with all of Pfizer's external stakeholders overseeing Communications, Corporate Responsibility, Global Policy, Government Relations, Investor Relations, and Patient Advocacy. She also serves as Vice Chair of The Pfizer Foundation.   Before joining Pfizer, Sally held several senior Communications and Government Relations roles at Estée Lauder and American Express. Earlier in her career, Sally spent eight years on Capitol Hill focused on international trade issues.   Sally also serves as co-chair of The International Rescue Committee, one of the world's largest humanitarian aid organizations. Sally has been named a Top Voice on LinkedIn, a PRWeek Influencer 50, a PRovoke.com Influence 100 member, and was ranked as number two on FastCompany's Queer 50 List, in addition to many more top industry lists.   Being at the forefront of the fight against COVID with Pfizer's vaccine efforts, the past two years have marked a series of unique challenges for Sally and the Pfizer team, culminating with the brand achieving top ten brand status and becoming a favorable household name across America. In this interview with Lippe Taylor CEO Paul Dyer, Sally discusses these challenges and how she and her team were able to overcome the adversity of the past twenty-four months.   Planning is Important, but Adaptability Moreso President Eisenhower once said: "In preparing for battle, I have always found that plans are useless, but planning is indispensable." The past couple years have been a whirlwind for Sally and the entire Pfizer team, but they weathered the storm and came out as a top ten brand in the world. Sally attributes it to adaptability, stating: "You can write the best plan in the world, but it's really about being able to be nimble and move with what's happening, and planning is a sort of continuous process."   It may be easy to say that Pfizer's reputation skyrocketed because, well… they kind of saved the world. However, Sally reminds us that Pfizer stood the risk of becoming a political tool when Presidential candidates began making vaccine promises in hotly contested debates and news cycles. There was every opportunity for this to become a year of crisis rather than positivity. According to Sally, Pfizer was able to transform from “a brand with a reputational struggle to a top ten brand” during this time because, in addition to doing the right thing, they were able to dynamically course-correct and modify their plan as it unfolded.    Stay Thirsty, My Friends After Pfizer was named a top ten brand, Sally's immediate instinct was not to celebrate but to ensure the company didn't rest on its laurels. “I always think the greatest threat, both externally and culturally, is any sense of self-satisfaction or really arrogance and complacency," she explains. Therefore, instead of allowing the recognition to breed complacency, she challenged her team to keep their foot on the gas. As a result, Pfizer hasn't slowed down its innovation, as evidenced by their recent https://www.tiktok.com/tag/pfizerpartner (TikTok campaign) combating vaccine misinformation - a first for Pharma. “There have been times when my team has proposed something, and I say, "Let's do it," and then we get blow-back very swiftly. Do you know what we do? We take it down, and we move on. You can't succeed in this realm if you're not willing to fail in this realm,” she explains.   It's Ok to Own your Narrative Sally recounts a story where she felt frustrated that media outlets preferred to politicize the vaccine debate rather than publicize the sound byline...

In this episode of The Corporate Director Podcast, hear from Sally Susman, Executive Vice President and Chief Corporate Affairs Officer at Pfizer, as she takes us inside the process to create a COVID-19 vaccine, dubbed “Project Lightspeed,” and what she learned about leadership and governance along the way.

Podcast topics: 2:27 - Susman talks about heading up comms for Pfizer during the sprint to develop the first coronavirus vaccine in record time, how to communicate vaccine safety effectively and respectfully, whether fully vaccinated people will need booster shots and and more.11:51 - The PRWeek Power List hits its 15th anniversary; plus, what notable trends are apparent from the 50 honorees on this year's list and why a background in politics is an asset for today's comms pros. 19:57 - The Olympic Games will kick off in Tokyo this year after being delayed in 2020 due to the pandemic. What do the restrictions look like and what will they mean for sponsors, advertisers, and fans?22:06 - Remembering MSL chief innovation officer Bryan Pedersen after his passing this weekend. 23:08 - Finn Partners acquires Barokas.24:45 - The novelty food trend continues with Kraft launching a macaroni and cheese ice cream in partnership with Van Leeuwen Ice Cream.

Susman talks about leading the comms around coronavirus vaccines, the evolution of the pharma industry's reputation and more. From PRWeek

In this episode of Capital for Good, we speak with Sally Susman, Executive Vice President and Chief Corporate Affairs Office at Pfizer, about leadership, innovation, breakthroughs and partnership – in these extraordinary times. In this conversation, Susman gives us insight into what it has been like to work at Pfizer – a company center stage in a global pandemic developing, manufacturing and rolling out the first vaccine approved by the FDA for Emergency Use Authorization in the United States in record time, balancing speed and urgency with scientific rigor and patient safety.  Susman discusses how “breakthroughs beget breakthroughs” and how the last year has led to innovations in process (in drug development) and partnerships (with other companies and governments).  We discuss the critical importance of trust – in science and in the biopharmaceutical industry more broadly – and how historic and current investments in health equity and access, in the United States and around the world, are essential.  We also explore Pfizer's role as a global and local citizen, including the company's commitment to remain headquartered in New York City, and to rebuilding the city it has called home since its founding in 1849.  We end with a discussion of Pfizer's corporate values – courage, excellence, equity, and joy – and in particular the joy that has come from millions of people being vaccinated. This episode was recorded on February 12, 2021. Therefore a few statements, such as Johnson & Johnson's application to the FDA for Emergency Use Authorization, may be outdated.   About Sally Susman As Executive Vice President and Chief Corporate Affairs Officer, Sally Susman leads engagement with all of Pfizer's external stakeholders overseeing global policy, communications, government relations, corporate responsibility, investor relations and the Chief Patient Office. She also serves as vice chair of The Pfizer Foundation. Before joining Pfizer in 2007, Susman held several senior communications and government relations roles at Estée Lauder Companies and the American Express Company, including a posting in London with responsibility for all of Europe. Earlier in her career, she spent eight years on Capitol Hill focused on international trade issues and was Deputy Assistant Secretary for Legislative Affairs in the Clinton Administration. Currently, Susman serves as co-chair of The International Rescue Committee, one of the world's largest humanitarian aid organizations, and on the board of WPP, the U.K.-based global advertising and marketing company. She is also a member of the Council on Foreign Relations. She is a frequent commentator in newspapers, magazines, podcasts and broadcast programs and was named a 2019 Top Voice on LinkedIn. Susman graduated from Connecticut College with a B.A. in government and studied at the London School of Economics.   Mentioned in this Episode Why Pfizer says it pushed for transparency and diversity in vaccine development process Marketplace November 9, 2020 WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access December 31, 2020 COVAX announces new agreement, plans for first deliveries January 22, 2021 Pfizer expects to cut COVID-19 vaccine production time by close to 50% as production ramps up, efficiencies increase USA Today February 7, 2021 UNICEF signs supply agreement for Pfizer/BioNTech COVID-19 Vaccine February 11, 2021 Sally Susman, A Valentine to New York City February 14, 2001

Recorded January 04, 2021Current Episodes at https://walkinverse.buzzsprout.com/I am moving all podcast here slowly. I will keep buzzsprout for all public reports and here for member only content.Report #30, "Meet Pfizer & A Few Connections." In this episode, we will dig a bit into Pfizer and their connections. We will look at some of the CEO comments and ask the question, why?  Why did the FDA give clearance to an untested technology never licensed for human use? Grab a pen and notebook and enjoy the report.Did you like the report?We walked into 2021 with more mandates. Genocide by vaccination became a true possibility. Now, the hour's at hand, and we must know who's behind Pfizer. Our government guarantees the demise of the American people. Through illegal taxation without representation, their demise is imminent. America's government gave away tax dollars for absolute financial destruction. They'll fund Big Pharma to combat a virus with a 99.9% survival rate. It's utter insanity.Behind these treasonous acts lies Albert Bourla. He started his career over twenty-five years (Prizer. 2020) ago at Pfizer and climbed through the ranks to CEO. With his in-depth knowledge and recent remarks, we must question his motives. Through emergency authorization (FDA. 2020), the FDA gave the green light. Inject everyone and distribute experimental therapies throughout the United States. They skipped standard animal trials and jumped to human vaccination (F. William Engdahl. 2020).The effectiveness—unknown. Even after injected, spread may occur (Baker, Sinéad. 2020). Short and long term side effects (vaccine injury) lurk in the shadows.Yet, the FDA feels the benefits outweigh the risk of ending a non-existent pandemic. A pandemic of such importance, the CEO of Pfizer sold $5.6 million, 62% of his stock (F. William Engdahl. 2020) the same day they reported positive results for their mRNA injectable technology (Paul R. La Monica. 2020). Not only did the CEO profit, so did his VP. Sally Susman walked away with $1.8 million on the same day. This came a few months after executives at Moderna dumped $30 million of their stock. Which the SEC officials wants investigated for illegal market manipulation. The press questioned Albert about the finances Pfizer received from the Trump Administration for distribution and development—he denied it; he lied. Asked if he would take part in the COVID mRNA injection rollout, he stated,“I'm 59 years old, in good health, I'm not working in the front line. So, my type is not recommended to get vaccinated…” (Daniel. 2020).But for others, they should accept the needle because the plight which he wishes, “wasn't so critical so they (the people) could have the luxury to think about it (the injection). The situation is as deadly as it could be right now..” touts Albert. He continues, “trust science and get injected to protect the ones you love.” Yet, he's 59. In good health and doesn't need the vaccine, nor do the executives of the company (CNBC Television. 2020).Watch Video => https://www.bitchute.com/video/MDOopH6fFUMt/And like Albert, the FDA maintains the narrative, “all those sixteen and older should receive the COVID vaccine.” But interestingly enough, by the CEO's admission, if not on the front lines and your vigor good, no need for their injection.I then ask why. Why must the narrative of vaccination for all continue? One answer, profits and the elite forces behind the initiative.The Gates Foundation (Speights, Keith. 2020) owns stocks in BioNTech, CureVac, Vír BioTechnology, and Pfizer. On top of his positions in these enterprises, BioNTech revealed a new partnership. The development of HIV and TB programs with an initial investment of $55 million to cap at $100 million (NA. 2019. ). An oddity with the mRNA rollout centers on HIV. A cause Bill champions throughout Africa. In Australia, several individuals tested false positive for HIV after vaccinations (Tyler Durden. 2020). Yet, an established pharmaceutical expert, Fourtillian, made it known about a patent filed in 2011 for SARS-CoV-2. On December 10, 2020, they arrested him and seized all his research. Computers taken, bank account frozen, all income confiscated. His findings showed not only the dangers of the vaccines, but how they contained four sequences of HIV (Jeanne Smits. 2020). In South Africa, over 50% of pharmaceutical funds surround drugs for HIV (ltd, Research and Markets. 2020). A shared interest between the Gates Foundation and these pharmaceutical giants.Other shareholders of Pfizer, include BlackRock, JP Morgan, Chase & Co, Morgan Stanley, Bank of America, and Bank of New York Mellon. Big Tech (a mix of Apple, Microsoft, Amazon, Facebook, and Google) represents up to 15% of their portfolios, which encompass contract tracing, censorship, and digital identification (stockzoa. 2021).These companies have one idea in mind, and it's not to benefit humanity. With the investments, Pfizer guarantees investors a hundredfold return on their new DNA based vaccine. According to Fierce Pharma, each dose, $20. Each individual needs two. Forty per person, times 7.8 billion people, you do the math (David, Emilia. 2020). And when new viruses peak, the health passport reminds, “it's time for your shot,” as the revenue flows in. If you refuse to partake, too late, your accounts offline until you comply. Disobey—destitution your home. But, the bankers move in lockstep with the future they designed for you. As propaganda continues, between 88 and 100 million people lost everything. Thrown into extreme poverty because of a pandemic orchestrated by world billionaires (Zumbrun, Josh. 2020).Before you accept any of these experimental genetic therapies, think twice. I can't tell you what to do, but I'll tell you this. The government and political figures fabricate stories daily. They removed your rights and liberties from the start. If you believe COVID can kill you, roll up your sleeve—take your shot. There's nothing I can say to show the level of propaganda you're fed continually.For those who see it at face value, take a stand. Scream from the rooftops, “No more, we won't accept tyranny!”Reject all unconstitutional and illegal orders, for there are more of us than them.Stand fast, the rides about to get bumpy.References* Prizer. 2020. “Albert Bourla, DVM, Ph.D. | Pfizer.” Company. Pfizer.Com. 2020.* FDA. 2020. “FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine.” Government. FDA. FDA. December 14, 2020.* F. William Engdahl. 2020. “What's Not Being Said About the Pfizer Coronavirus Vaccine. ‘Human Guinea Pigs'?” Global Research. December 5, 2020.* Baker, Sinéad. 2020. “Pfizer's Chairman Says It's Not Clear Whether People Who Are Vaccinated Can Still Spread COVID-19.” Business Insider. December 4, 2020.* Paul R. La Monica. 2020. “Pfizer's CEO Sold $5.6 Million in Stock the Day He Announced Promising Vaccine News.” CNN. November 11, 2020.* Daniel. 2020. “Pfizer CEO Albert Bourla Says He Will NOT Get the Vaccine — For Now, That Is.” We Love Trump. December 15, 2020.* CNBC Television. 2020. Pfizer CEO Albert Bourla on Vaccine Hesitancy: “Trust Science.”* Speights, Keith. 2020. “4 Coronavirus Vaccine Stocks the Bill & Melinda Gates Foundation Is Betting On.” The Motley Fool. September 24, 2020.* NA. 2019. “BioNTech Announces New Collaboration to Develop HIV and Tuberculosis Programs.” Business Wire. September 4, 2019.* Tyler Durden. 2020. “Australia Cancels COVID Vaccine Trial Over ‘Unexpected' False Positives For HIV.” ZeroHedge. December 11, 2020.* Jeanne Smits. 2020. “Accomplished Pharma Prof Thrown in Psych Hospital after Questioning Official COVID Narrative.” LifeSiteNews. December 11, 2020.* ltd, Research and Markets. 2020. “The Pharmaceutical Industry in South Africa 2020.” Research Database. Research and Markets. December 2020.* stockzoa. 2021. “Who Owns Pfizer? Top Stakeholders of PFE According to 13F Filings.” Finance. Stockzoa. February 15, 2021.* David, Emilia. 2020. “How Much Could Pfizer's Coronavirus Vaccine Cost?” Grunge.Com. November 9, 2020.* Zumbrun, Josh. 2020. “Coronavirus Has Thrown Around 100 Million People Into Extreme Poverty, World Bank Estimates.” Wall Street Journal, October 7, 2020, sec. Economy. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit walkinverse.substack.com/subscribe

We're talking about the next step of the pandemic, WW2-era child refugees and a look inside the White House— new episode, streaming now with * Sally Susman, Pfizer Executive Vice President/Chief Corporate Affairs Officer. She is also vice chair of the Pfizer Foundation and co-chair of Pfizer's Political Action Committee; * Mary Jordan, a Pulitzer Prize-winning American journalist, best-selling author and National Correspondent for the Washington Post; * and author Mikhal Dekel who teaches English and Comparative Literature at the City College and the CUNY Graduate Center, and directs CCNY's Rifkind Center for the Humanities and Arts. With, as always, music from the extremely talented American Pops Orchestra!

Sally Susman, Executive Vice President and Chief Corporate Affairs Officer at Pfizer As Executive Vice President and Chief Corporate Affairs Officer at Pfizer, Sally Susman directs the company's communications, public affairs, philanthropic and patient engagement activities around the world. Currently, Susman serves on the board of WPP, the UK-based global advertising and marketing company, and as co-chair of the International Rescue Committee. She is also a member of the Council on Foreign Relations. Before joining Pfizer in 2007, Susman held roles at Estée Lauder Companies and the American Express Company. Earlier in her career, she spent eight years in government service focused on international trade issues. Susman is a frequent commentator in newspapers, magazines and broadcast programs and was named a 2019 Top Voice on LinkedIn. --- Support this podcast: https://anchor.fm/toby-usnik/support

Welcome to my weekly 30-minute fireside chat with amazing business leaders who are committed to CSR (Corporate Social Responsibility). Each week together we will meet bold, successful and highly responsible business leaders, including Sally Susman, Chief Corporate Affairs Officer for the $51B pharmaceutical giant Pfizer, and Joe Evangelisti, MD and Chief Global Communications Officer at the $115B banking powerhouse JPMorgan Chase. Together we will find out how they and their brands are advancing both purpose and profit. We will explore timely challenges from the Covid 19 pandemic, the killing of George Floyd and #BLM, and climate change, to name a few. We will get a bird's-eye view of how great global brands are engaging with the greatest social and planetary challenges of our times. Toby Usnik, Author of The Caring Economy: How to Win with Corporate Social Responsibility (CSR), and founder of Philanthropic Impact (π) helps individuals and organizations define and create their legacies. For leaders who understand that making a mark in business or achieving a level of personal success is not enough, π brings a unique approach to translating their values into making a sustainable difference in the world. In an increasingly interconnected world, people are drawn to businesses and organizations that express authentic values and execute on them. “We make a living by what we get, but make a life by what we give.” – Winston Churchill --- Support this podcast: https://anchor.fm/toby-usnik/support

In August of 2019, Lippe Taylor hosted an event called Taking Your Seat at the Table: Strategies for Reaching the C-Suite as a Woman. The centerpiece of the evening was a roundtable discussion on the topic of executive female leadership. The discussion was intended to distill the key lessons each woman learned from their respective rise to seniority and their advice for future generations of female leaders. This episode features full audio from the event and a distillation of the wisdom and key insights from all of our guests.  Key Links and Info for our Guests Executive Vice President and Chief Corporate Affairs Officer for Pfizer, Sally Susman's https://www.pfizer.com/people/leadership/executives/sally_susman (business bio) || https://www.linkedin.com/in/sallysusman (LinkedIn profile). Head of Corporate Communications at Citi, Jennifer Lowney's https://www.linkedin.com/in/jennifer-lowney-817b425 (LinkedIn profile) || Her https://twitter.com/lowneyjen?lang=en (Twitter page). EVP Corporate Communications at Scholastic, Stephanie Smirnov's https://www.linkedin.com/in/ssmirnov (LinkedIn profile) || Her https://twitter.com/ssmirnov?lang=en (Twitter page). Global Executive Director, Communications at Merck, Joanna Breitstein's https://www.linkedin.com/in/joannabreitstein (LinkedIn profile).  Former Senior Vice President and Chief Communications Officer at Vertex Pharmaceuticals, Kym White's https://www.linkedin.com/in/kym-white-171a9b26 (LinkedIn profile).  Director of External Communications and Customer Success, Pernod Ricard USA at Pernod Ricard, Taylor Foxman's https://www.linkedin.com/in/taylor-foxman (LinkedIn profile). [The roundtable was moderated by] The Former Chief Digital Officer of Bayer, https://www.linkedin.com/in/jessicafederer (Jessica Federer), and The CEO of Lippe Taylor, https://lippetaylor.com/about/profiles/maureen-lippe (Maureen Lippe).  ---- The discussion was intended to distill the key lessons each woman learned from their respective rise to seniority and their advice for future generations of female leaders. Below are our key takeaways from the evening. ---- Key Takeaways: Don't wait for an invitation. As Sally Susman shares, getting ahead in male-dominated fields means you invite yourself to events. Or, in other words, you can learn to play golf just like Sally did. She learned that by playing golf, she wouldn't be left behind or excluded. By being proactive and not backing off by an inch, Sally ensured her inclusion in the company.  Have an analytical approach to inclusion and for fighting bias. Jennifer Lowney of Citi accentuated the importance of leaning on data as a concrete tool for staving off unconscious gender bias. Citi does this through a hired third-party analyst who measures trends in real-time to report any instances of unconscious bias in talent acquisition spheres or internal operations. There's no ‘I' in ‘team'...and that's just fine. As Kym White says, women often find themselves deflecting the credit that would drive professional advancement instead of accepting it. This is often done by giving credit to the team instead of individually claiming ownership. True credit gets lost within the team (or applied to men) when women are encouraged not to take credit for their actions. Find accomplices, not allies, sponsors, not mentors. As Stephanie Smirnov puts it, sponsors can be crucial for your development as a professional. A sponsor will coach you and push you farther than a mentor. And when differentiating between an ally and an accomplice: an ally will fight with you, but an accomplice will fight for you because they are inextricably dedicated to your professional development. Find yourself an accomplice! During a crisis, focus on unity and not division. Joanna Breitstein used the #MeToo Movement to illustrate how companies can come together and focus on organizational openness and communication on...

The team also gives its thoughts on the week's top news in PR and communications, which includes W2O Group's Bob Pearson stepping down; Martin Sorrell unveiling his plans for S4 Capital; MDC seeking a new CEO; and Apple's new product launch.